{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:41:36Z","timestamp":1784666496528,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81761128021, 81771452"],"award-info":[{"award-number":["81761128021, 81771452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006739","name":"Capital Foundation of Medical Development","doi-asserted-by":"publisher","award":["CFH 2020-2-2132"],"award-info":[{"award-number":["CFH 2020-2-2132"]}],"id":[{"id":"10.13039\/501100006739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["European Union Regional Developmental Fund Mobilitas Pluss Program No. MOBTT77"],"award-info":[{"award-number":["European Union Regional Developmental Fund Mobilitas Pluss Program No. MOBTT77"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A number of tryptophan metabolites known to be neuroactive have been examined for their potential associations with cognitive deficits in schizophrenia. Among these metabolites, kynurenic acid (KYNA), 5-hydroxyindole (5-HI), and quinolinic acid (QUIN) are documented in their diverse effects on \u03b1-7 nicotinic acetylcholine receptor (\u03b17nAChR) and\/or <jats:italic>N<\/jats:italic>-methyl-D-aspartate receptor (NMDAR), two of the receptor types thought to contribute to cognitive impairment in schizophrenia. In this study, serum levels of KYNA, 5-HI, and QUIN were measured in 195 patients with schizophrenia and in 70 healthy controls using liquid chromatography-tandem mass spectrometry; cognitive performance in MATRICS Consensus Cognitive Battery and cortical thickness measured by magnetic resonance imaging were obtained. Patients with schizophrenia had significantly lower serum KYNA (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and QUIN (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) levels, and increased 5-HI\/KYNA (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and QUIN\/KYNA ratios (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) compared with healthy controls. Multiple linear regression showed that working memory was positively correlated with serum 5-HI levels (<jats:italic>t<\/jats:italic>\u2009=\u20092.10, <jats:italic>p<\/jats:italic>\u2009=\u20090.04), but inversely correlated with KYNA concentrations (<jats:italic>t<\/jats:italic>\u2009=\u2009\u22122.01, <jats:italic>p<\/jats:italic>\u2009=\u20090.05) in patients. Patients with high 5-HI and low KYNA had better working memory than other subgroups (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). Higher 5-HI levels were associated with thicker left lateral orbitofrontal cortex (<jats:italic>t<\/jats:italic>\u2009=\u20093.71, <jats:italic>p<\/jats:italic>\u2009=\u20092.94\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>) in patients. The different effects of 5-HI and KYNA on working memory may appear consistent with their opposite receptor level mechanisms. Our findings appear to provide a new insight into the dynamic roles of tryptophan pathway metabolites on cognition, which may benefit novel therapeutic development that targets cognitive impairment in schizophrenia.<\/jats:p>","DOI":"10.1038\/s41398-021-01311-z","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T08:04:38Z","timestamp":1617264278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia"],"prefix":"10.1038","volume":"11","author":[{"given":"Junchao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kochunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Chiappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baopeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0222-7076","authenticated-orcid":false,"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3912","authenticated-orcid":false,"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Elliot","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten, M., Nollen, E. A. A., Rohrig, U. F., Fallarino, F. & Opitz, C. A. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat. Rev. Drug Discov. 18, 379\u2013401 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1311_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz, R., Bruno, J. P., Muchowski, P. J. & Wu, H. Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13, 465\u2013477 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"1311_CR3","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1523\/JNEUROSCI.5631-03.2004","volume":"24","author":"M Alkondon","year":"2004","unstructured":"Alkondon, M. et al. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J. Neurosci. 24, 4635\u20134648 (2004).","journal-title":"J. Neurosci."},{"key":"1311_CR4","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas, C. et al. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21, 7463\u20137473 (2001).","journal-title":"J. Neurosci."},{"key":"1311_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s002130050667","volume":"138","author":"ED Levin","year":"1998","unstructured":"Levin, E. D. & Simon, B. B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138, 217\u2013230 (1998).","journal-title":"Psychopharmacology"},{"key":"1311_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0306-4522(97)00224-8","volume":"81","author":"R Felix","year":"1997","unstructured":"Felix, R. & Levin, E. D. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81, 1009\u20131017 (1997).","journal-title":"Neuroscience"},{"key":"1311_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0074-7742(06)78008-4","volume":"78","author":"LF Martin","year":"2007","unstructured":"Martin, L. F. & Freedman, R. Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int. Rev. Neurobiol. 78, 225\u2013246 (2007).","journal-title":"Int. Rev. Neurobiol."},{"key":"1311_CR8","first-page":"33","volume":"42","author":"SI Deutsch","year":"2005","unstructured":"Deutsch, S. I. et al. Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophrenia. Isr. J. psychiatry Relat. Sci. 42, 33\u201344 (2005).","journal-title":"Isr. J. psychiatry Relat. Sci."},{"key":"1311_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/schbul\/sbl033","volume":"33","author":"AC Chess","year":"2007","unstructured":"Chess, A. C., Simoni, M. K., Alling, T. E. & Bucci, D. J. Elevations of endogenous kynurenic acid produce spatial working memory deficits. Schizophr. Bull. 33, 797\u2013804 (2007).","journal-title":"Schizophr. Bull."},{"key":"1311_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","volume":"50","author":"R Schwarcz","year":"2001","unstructured":"Schwarcz, R. et al. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50, 521\u2013530 (2001).","journal-title":"Biol. Psychiatry"},{"key":"1311_CR11","doi-asserted-by":"publisher","unstructured":"Kindler, J. et al. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-41019-40401-41389 (2019).","DOI":"10.1038\/s41380-41019-40401-41389"},{"key":"1311_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","volume":"52","author":"M Kessler","year":"1989","unstructured":"Kessler, M., Terramani, T., Lynch, G. & Baudry, M. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52, 1319\u20131328 (1989).","journal-title":"J. Neurochem."},{"key":"1311_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","volume":"37","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam, B. & Javitt, D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 4\u201315 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"1311_CR14","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1073\/pnas.93.21.11962","volume":"93","author":"DC Javitt","year":"1996","unstructured":"Javitt, D. C., Steinschneider, M., Schroeder, C. E. & Arezzo, J. C. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl Acad. Sci. USA 93, 11962\u201311967 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1311_CR15","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1038\/npp.2013.170","volume":"38","author":"NR Driesen","year":"2013","unstructured":"Driesen, N. R. et al. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology 38, 2613\u20132622 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1311_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/schbul\/sbw193","volume":"43","author":"JK Forsyth","year":"2017","unstructured":"Forsyth, J. K. et al. Effects of augmenting N-methyl-D-aspartate receptor signaling on qorking memory and experience-dependent plasticity in schizophrenia: an exploratory study using acute d-cycloserine. Schizophr. Bull. 43, 1123\u20131133 (2017).","journal-title":"Schizophr. Bull."},{"key":"1311_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4615-5945-0_4","volume":"420","author":"F Moroni","year":"1997","unstructured":"Moroni, F. et al. Studies on the pharmacological properties of oxindole (2-hydroxyindole) and 5-hydroxyindole: are they involved in hepatic encephalopathy? Adv. Exp. Med. Biol. 420, 57\u201373 (1997).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1311_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0028-3908(02)00094-1","volume":"43","author":"R Zwart","year":"2002","unstructured":"Zwart, R. et al. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacology 43, 374\u2013384 (2002).","journal-title":"Neuropharmacology"},{"key":"1311_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/sj.bjp.0706914","volume":"149","author":"M Grilli","year":"2006","unstructured":"Grilli, M. et al. Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Br. J. Pharmacol. 149, 724\u2013732 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"1311_CR20","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1172\/JCI106921","volume":"51","author":"JA Schafer","year":"1972","unstructured":"Schafer, J. A. & Andreoli, T. E. Cellular constraints to diffusion. The effect of antidiuretic hormone on water flows in isolated mammalian collecting tubules. J. Clin. Investig. 51, 1264\u20131278 (1972).","journal-title":"J. Clin. Investig."},{"key":"1311_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bjp.0705007","volume":"138","author":"G Mannaioni","year":"2003","unstructured":"Mannaioni, G., Carpenedo, R. & Moroni, F. 5-hydroxyindole causes convulsions and increases transmitter release in the CA1 region of the rat hippocampus. Br. J. Pharmacol. 138, 245\u2013253 (2003).","journal-title":"Br. J. Pharmacol."},{"key":"1311_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1113\/jphysiol.2006.104794","volume":"574","author":"MH Mok","year":"2006","unstructured":"Mok, M. H. & Kew, J. N. Excitation of rat hippocampal interneurons via modulation of endogenous agonist activity at the alpha7 nicotinic ACh receptor. J. Physiol. 574, 699\u2013710 (2006).","journal-title":"J. Physiol."},{"key":"1311_CR23","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/ejn.12160","volume":"37","author":"S Beggiato","year":"2013","unstructured":"Beggiato, S. et al. Kynurenic acid, by targeting alpha7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo. Eur. J. Neurosci. 37, 1470\u20131477 (2013).","journal-title":"Eur. J. Neurosci."},{"key":"1311_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00213-003-1673-x","volume":"174","author":"DA Lewis","year":"2004","unstructured":"Lewis, D. A., Volk, D. W. & Hashimoto, T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology 174, 143\u2013150 (2004).","journal-title":"Psychopharmacology"},{"key":"1311_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopsych.2013.07.026","volume":"75","author":"TA Lett","year":"2014","unstructured":"Lett, T. A., Voineskos, A. N., Kennedy, J. L., Levine, B. & Daskalakis, Z. J. Treating working memory deficits in schizophrenia: a review of the neurobiology. Biol. Psychiatry 75, 361\u2013370 (2014).","journal-title":"Biol. Psychiatry"},{"key":"1311_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.biopsych.2014.09.007","volume":"77","author":"MT Tse","year":"2015","unstructured":"Tse, M. T., Piantadosi, P. T. & Floresco, S. B. Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical research. Biol. Psychiatry 77, 929\u2013939 (2015).","journal-title":"Biol. Psychiatry"},{"key":"1311_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares, R. G. et al. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem. Int. 40, 621\u2013627 (2002).","journal-title":"Neurochem. Int."},{"key":"1311_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0006-8993(83)91084-3","volume":"259","author":"MN Perkins","year":"1983","unstructured":"Perkins, M. N. & Stone, T. W. Quinolinic acid: regional variations in neuronal sensitivity. Brain Res. 259, 172\u2013176 (1983).","journal-title":"Brain Res."},{"key":"1311_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03605.x","volume":"939","author":"TP Obrenovitch","year":"2001","unstructured":"Obrenovitch, T. P. Quinolinic acid accumulation during neuroinflammation. Does it imply excitotoxicity? Ann. N. Y. Acad. Sci. 939, 1\u201310 (2001).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1311_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/exnr.1998.6767","volume":"150","author":"DA Shear","year":"1998","unstructured":"Shear, D. A. et al. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Exp. Neurol. 150, 305\u2013311 (1998).","journal-title":"Exp. Neurol."},{"key":"1311_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0304-3940(93)90752-7","volume":"149","author":"F Block","year":"1993","unstructured":"Block, F., Kunkel, M. & Schwarz, M. Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats. Neurosci. Lett. 149, 126\u2013128 (1993).","journal-title":"Neurosci. Lett."},{"key":"1311_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep36489","volume":"6","author":"A Latif-Hernandez","year":"2016","unstructured":"Latif-Hernandez, A. et al. Quinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticity. Sci. Rep. 6, 36489 (2016).","journal-title":"Sci. Rep."},{"key":"1311_CR33","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41386-018-0072-2","volume":"43","author":"J Chiappelli","year":"2018","unstructured":"Chiappelli, J. et al. Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia. Neuropsychopharmacology 43, 1706\u20131711 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"1311_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cne.903490302","volume":"349","author":"E Dominguez del Toro","year":"1994","unstructured":"Dominguez del Toro, E., Juiz, J. M., Peng, X., Lindstrom, J. & Criado, M. Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J. Comp. Neurol. 349, 325\u2013342 (1994).","journal-title":"J. Comp. Neurol."},{"key":"1311_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1113\/JP275226","volume":"596","author":"M Carta","year":"2018","unstructured":"Carta, M., Srikumar, B. N., Gorlewicz, A., Rebola, N. & Mulle, C. Activity-dependent control of NMDA receptor subunit composition at hippocampal mossy fibre synapses. J. Physiol. 596, 703\u2013716 (2018).","journal-title":"J. Physiol."},{"key":"1311_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","volume":"67","author":"N Andreasen","year":"2010","unstructured":"Andreasen, N., Pressler, M., Nopoulos, P., Miller, D. & Ho, B. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 67, 255\u2013262 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1311_CR37","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"D Gardner","year":"2010","unstructured":"Gardner, D., Murphy, A., O'Donnell, H., Centorrino, F. & Baldessarini, R. International consensus study of antipsychotic dosing. Am. J. Psychiatry 167, 686\u2013693 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"1311_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.schres.2015.09.003","volume":"169","author":"C Shi","year":"2015","unstructured":"Shi, C. et al. The MATRICS Consensus Cognitive Battery (MCCB): co-norming and standardization in China. Schizophrenia Res. 169, 109\u2013115 (2015).","journal-title":"Schizophrenia Res."},{"key":"1311_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","volume":"165","author":"KH Nuechterlein","year":"2008","unstructured":"Nuechterlein, K. H. et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am. J. Psychiatry 165, 203\u2013213 (2008).","journal-title":"Am. J. Psychiatry"},{"key":"1311_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.2007.07010043","volume":"165","author":"RS Kern","year":"2008","unstructured":"Kern, R. S. et al. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am. J. Psychiatry 165, 214\u2013220 (2008).","journal-title":"Am. J. Psychiatry"},{"key":"1311_CR41","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archpsyc.64.5.532","volume":"64","author":"D Dickinson","year":"2007","unstructured":"Dickinson, D., Ramsey, M. E. & Gold, J. M. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch. Gen. Psychiatry 64, 532\u2013542 (2007).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1311_CR42","doi-asserted-by":"publisher","first-page":"111043","DOI":"10.1016\/j.pscychresns.2020.111043","volume":"297","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: a comparison with matched treatment-responsive patients and healthy controls (\u2730, \u2730\u2730, \u2605, \u2605\u2605). Psychiatry Res. Neuroimaging 297, 111043 (2020).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"1311_CR43","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1097\/00001756-199711100-00017","volume":"8","author":"EM Urbanska","year":"1997","unstructured":"Urbanska, E. M., Kocki, T., Saran, T., Kleinrok, Z. & Turski, W. A. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. Neuroreport 8, 3501\u20133505 (1997).","journal-title":"Neuroreport"},{"key":"1311_CR44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/schbul\/sbq086","volume":"38","author":"KR Linderholm","year":"2012","unstructured":"Linderholm, K. R. et al. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr. Bull. 38, 426\u2013432 (2012).","journal-title":"Schizophr. Bull."},{"key":"1311_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","volume":"37","author":"KV Sathyasaikumar","year":"2011","unstructured":"Sathyasaikumar, K. V. et al. Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr. Bull. 37, 1147\u20131156 (2011).","journal-title":"Schizophr. Bull."},{"key":"1311_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341\u2013355 (2002).","journal-title":"Neuron"},{"key":"1311_CR47","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968\u2013980 (2006).","journal-title":"NeuroImage"},{"key":"1311_CR48","doi-asserted-by":"crossref","unstructured":"Wong, T. Y. et al. An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium. Psychol. Med. 50, 2034\u20132045 (2020).","DOI":"10.1017\/S0033291719002149"},{"key":"1311_CR49","doi-asserted-by":"crossref","unstructured":"King, L. J., Parke, D. V. & Williams, R. T. The metabolism of [2-14C] indole in the rat. Biochem. J. 98, 266\u2013277 (1966).","DOI":"10.1042\/bj0980266"},{"key":"1311_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.0906112107","volume":"107","author":"T Bansal","year":"2010","unstructured":"Bansal, T., Alaniz, R. C., Wood, T. K. & Jayaraman, A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc. Natl Acad. Sci. USA 107, 228\u2013233 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1311_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00391888","volume":"109","author":"DA Karlin","year":"1985","unstructured":"Karlin, D. A., Mastromarino, A. J., Jones, R. D., Stroehlein, J. R. & Lorentz, O. Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer. J. Cancer Res. Clin. Oncol. 109, 135\u2013141 (1985).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1311_CR52","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1073\/pnas.0812874106","volume":"106","author":"WR Wikoff","year":"2009","unstructured":"Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698\u20133703 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1311_CR53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tim.2015.08.001","volume":"23","author":"JH Lee","year":"2015","unstructured":"Lee, J. H., Wood, T. K. & Lee, J. Roles of indole as an interspecies and interkingdom signaling molecule. Trends Microbiol. 23, 707\u2013718 (2015).","journal-title":"Trends Microbiol."},{"key":"1311_CR54","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1046\/j.1471-4159.1998.70051998.x","volume":"70","author":"R Carpenedo","year":"1998","unstructured":"Carpenedo, R. & Mannaioni, G. Moroni F. Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure. J. Neurochem. 70, 1998\u20132003 (1998).","journal-title":"J. Neurochem."},{"key":"1311_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/archpsyc.1976.01770030045006","volume":"33","author":"AS Greenberg","year":"1976","unstructured":"Greenberg, A. S. & Coleman, M. Depressed 5-hydroxyindole levels associated with hyperactive and aggressive behavior. Relationship to drug response. Arch. Gen. Psychiatry 33, 331\u2013336 (1976).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1311_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12640-017-9714-0","volume":"32","author":"K Szymona","year":"2017","unstructured":"Szymona, K. et al. Correlations of kynurenic acid, 3-hydroxykynurenine, sIL-2R, IFN-alpha, and IL-4 with clinical symptoms during acute relapse of schizophrenia. Neurotox. Res. 32, 17\u201326 (2017).","journal-title":"Neurotox. Res."},{"key":"1311_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.88","volume":"7","author":"BE Wurfel","year":"2017","unstructured":"Wurfel, B. E. et al. Serum kynurenic acid is reduced in affective psychosis. Transl. Psychiatry 7, e1115 (2017).","journal-title":"Transl. Psychiatry"},{"key":"1311_CR58","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41386-018-0038-4","volume":"43","author":"J Chiappelli","year":"2018","unstructured":"Chiappelli, J. et al. Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia. Neuropsychopharmacology 43, 1675\u20131680 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"1311_CR59","first-page":"231","volume":"48","author":"A Ravikumar","year":"2000","unstructured":"Ravikumar, A., Deepadevi, K. V., Arun, P., Manojkumar, V. & Kurup, P. A. Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders. Neurol. India 48, 231\u2013238 (2000).","journal-title":"Neurol. India"},{"key":"1311_CR60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0269881108089583","volume":"23","author":"S Barry","year":"2009","unstructured":"Barry, S., Clarke, G., Scully, P. & Dinan, T. G. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. J. Psychopharmacol. 23, 287\u2013294 (2009).","journal-title":"J. Psychopharmacol."},{"key":"1311_CR61","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/schbul\/sbw221","volume":"43","author":"E Plitman","year":"2017","unstructured":"Plitman, E. et al. Kynurenic acid in schizophrenia: a systematic review and meta-analysis. Schizophr. Bull. 43, 764\u2013777 (2017).","journal-title":"Schizophr. Bull."},{"key":"1311_CR62","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y. & Smith, Q. R. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007\u20132017 (1991).","journal-title":"J. Neurochem."},{"key":"1311_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","volume":"5","author":"TA Pollak","year":"2018","unstructured":"Pollak, T. A. et al. The blood-brain barrier in psychosis. Lancet Psychiatry 5, 79\u201392 (2018).","journal-title":"Lancet Psychiatry"},{"key":"1311_CR64","doi-asserted-by":"crossref","unstructured":"Kealy, J., Greene, C. & Campbell, M. Blood-brain barrier regulation in psychiatric disorders. Neurosci. Lett. 726, 133664 (2020).","DOI":"10.1016\/j.neulet.2018.06.033"},{"key":"1311_CR65","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","volume":"105","author":"R Owe-Young","year":"2008","unstructured":"Owe-Young, R. et al. Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J. Neurochem. 105, 1346\u20131357 (2008).","journal-title":"J. Neurochem."},{"key":"1311_CR66","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jamapsychiatry.2014.243","volume":"71","author":"J Chiappelli","year":"2014","unstructured":"Chiappelli, J. et al. Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance. JAMA Psychiatry 71, 761\u2013768 (2014).","journal-title":"JAMA Psychiatry"},{"key":"1311_CR67","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1523\/JNEUROSCI.0932-17.2017","volume":"37","author":"E Flores-Barrera","year":"2017","unstructured":"Flores-Barrera, E. et al. Preferential disruption of prefrontal GABAergic function by nanomolar concentrations of the alpha7nACh negative modulator kynurenic acid. J. Neurosci. 37, 7921\u20137929 (2017).","journal-title":"J. Neurosci."},{"key":"1311_CR68","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/npp.2010.39","volume":"35","author":"MC Potter","year":"2010","unstructured":"Potter, M. C. et al. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology 35, 1734\u20131742 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"1311_CR69","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","volume":"34","author":"R Kozak","year":"2014","unstructured":"Kozak, R. et al. Reduction of brain kynurenic acid improves cognitive function. J. Neurosci. 34, 10592\u201310602 (2014).","journal-title":"J. Neurosci."},{"key":"1311_CR70","first-page":"309","volume":"45","author":"TW Stone","year":"1993","unstructured":"Stone, T. W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309\u2013379 (1993).","journal-title":"Pharmacol. Rev."},{"key":"1311_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/jm00031a015","volume":"37","author":"R Pellicciari","year":"1994","unstructured":"Pellicciari, R. et al. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem. 37, 647\u2013655 (1994).","journal-title":"J. Med. Chem."},{"key":"1311_CR72","unstructured":"Marx, W. et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol. Psychiatry 10.1038\/s41380-020-00951-9 (2020)."},{"key":"1311_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-8981(94)90130-9","volume":"227","author":"EW Holmes","year":"1994","unstructured":"Holmes, E. W., Russell, P. M., Kinzler, G. J. & Bermes, E. W. Jr Inflammation-associated changes in the cellular availability of tryptophan and kynurenine in renal transplant recipients. Clin. Chim. Acta 227, 1\u201315 (1994).","journal-title":"Clin. Chim. Acta"},{"key":"1311_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4137\/IJTR.S16800","volume":"7","author":"ME Kegel","year":"2014","unstructured":"Kegel, M. E. et al. Imbalanced kynurenine pathway in schizophrenia. Int. J. Tryptophan Res. 7, 15\u201322 (2014).","journal-title":"Int. J. Tryptophan Res."},{"key":"1311_CR75","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1523\/JNEUROSCI.4637-08.2009","volume":"29","author":"AH Lara","year":"2009","unstructured":"Lara, A. H., Kennerley, S. W. & Wallis, J. D. Encoding of gustatory working memory by orbitofrontal neurons. J. Neurosci. 29, 765\u2013774 (2009).","journal-title":"J. Neurosci."},{"key":"1311_CR76","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1523\/JNEUROSCI.0464-08.2008","volume":"28","author":"ML LoPresti","year":"2008","unstructured":"LoPresti, M. L. et al. Working memory for social cues recruits orbitofrontal cortex and amygdala: a functional magnetic resonance imaging study of delayed matching to sample for emotional expressions. J. Neurosci. 28, 3718\u20133728 (2008).","journal-title":"J. Neurosci."},{"key":"1311_CR77","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/35082081","volume":"411","author":"JD Wallis","year":"2001","unstructured":"Wallis, J. D., Anderson, K. C. & Miller, E. K. Single neurons in prefrontal cortex encode abstract rules. Nature 411, 953\u2013956 (2001).","journal-title":"Nature"},{"key":"1311_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14823","volume":"8","author":"R Nogueira","year":"2017","unstructured":"Nogueira, R. et al. Lateral orbitofrontal cortex anticipates choices and integrates prior with current information. Nat. Commun. 8, 14823 (2017).","journal-title":"Nat. Commun."},{"key":"1311_CR79","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1037\/abn0000369","volume":"127","author":"YT Cho","year":"2018","unstructured":"Cho, Y. T. et al. Effects of reward on spatial working memory in schizophrenia. J. Abnorm. Psychol. 127, 695\u2013709 (2018).","journal-title":"J. Abnorm. Psychol."},{"key":"1311_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","volume":"52","author":"J Savitz","year":"2015","unstructured":"Savitz, J. et al. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology 52, 200\u2013211 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"1311_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbi.2016.04.007","volume":"56","author":"KD Young","year":"2016","unstructured":"Young, K. D. et al. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav. Immun. 56, 335\u2013342 (2016).","journal-title":"Brain Behav. Immun."},{"key":"1311_CR82","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller, B. J., Buckley, P., Seabolt, W., Mellor, A. & Kirkpatrick, B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70, 663\u2013671 (2011).","journal-title":"Biol. Psychiatry"},{"key":"1311_CR83","doi-asserted-by":"crossref","unstructured":"Noto, C. et al. Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis. Int. J. Neuropsychopharmacol. 18, pyu042 (2014).","DOI":"10.1093\/ijnp\/pyu042"},{"key":"1311_CR84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","volume":"41","author":"A Stojanovic","year":"2014","unstructured":"Stojanovic, A. et al. Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology 41, 23\u201332 (2014).","journal-title":"Psychoneuroendocrinology"},{"key":"1311_CR85","doi-asserted-by":"publisher","first-page":"C836","DOI":"10.1152\/ajpcell.00053.2016","volume":"310","author":"M Schlittler","year":"2016","unstructured":"Schlittler, M. et al. Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans. Am. J. Physiol. Cell Physiol. 310, C836\u2013840 (2016).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1311_CR86","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5607\/en.2017.26.3.132","volume":"26","author":"KJ Lee","year":"2017","unstructured":"Lee, K. J. et al. High-fat diet and voluntary chronic aerobic exercise recover altered levels of aging-related tryptophan metabolites along the kynurenine pathway. Exp. Neurobiol. 26, 132\u2013140 (2017).","journal-title":"Exp. Neurobiol."},{"key":"1311_CR87","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuroimage.2018.06.065","volume":"179","author":"AK Rogge","year":"2018","unstructured":"Rogge, A. K., R\u00f6der, B., Zech, A. & H\u00f6tting, K. Exercise-induced neuroplasticity: Balance training increases cortical thickness in visual and vestibular cortical regions. NeuroImage 179, 471\u2013479 (2018).","journal-title":"NeuroImage"},{"key":"1311_CR88","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/YCO.0000000000000326","volume":"30","author":"P Falkai","year":"2017","unstructured":"Falkai, P., Malchow, B. & Schmitt, A. Aerobic exercise and its effects on cognition in schizophrenia. Curr. Opin. Psychiatry 30, 171\u2013175 (2017).","journal-title":"Curr. Opin. Psychiatry"},{"key":"1311_CR89","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","volume":"279","author":"TW Stone","year":"2012","unstructured":"Stone, T. W., Forrest, C. M. & Darlington, L. G. Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection. FEBS J. 279, 1386\u20131397 (2012).","journal-title":"FEBS J."},{"key":"1311_CR90","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint, A. M. Kynurenines: from the perspective of major psychiatric disorders. FEBS J. 279, 1375\u20131385 (2012).","journal-title":"FEBS J."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01311-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01311-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01311-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T12:53:32Z","timestamp":1669899212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01311-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01311-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.E.H. has received or plans to receive research funding or consulting fees on research projects from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Luye Pharma, Sound Pharma, Takeda, and Regeneron. None was involved in the design, analysis or outcomes of the study. All other authors declared that they have no conflicts of interest to this work and do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"198"}}